UBTFL7

Across TCGA pan-cancer cohorts, UBTFL7 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated UBTFL7 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher UBTFL7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated UBTFL7 expression acts as an unfavorable survival marker.

LIHC, SKCM, and THCA are the cancer types where UBTFL7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	II,III,IV	0.107	0.446	<.001	99	view →
SKCM	OS	Tertile	IV	0.179	0.755	<.001	60	view →
THCA	OS	Tertile	III,IV	0.815	0.979	.001	39	view →
ACC	DFS	Tertile	All	0.409	0.769	.003	27	view →
BRCA	DFS	Tertile	All	0.856	0.908	.023	18	view →
THYM	OS	Tertile	III,IV	0.701	0.944	.017	18	view →
CESC	DFS	Tertile	II,III,IV	0.638	0.807	.024	12	view →
CHOL	OS	Tertile	All	0.155	0.725	.029	9	view →
GBM	OS	Tertile	All	0.200	0.415	.045	9	view →
LUAD	OS	Tertile	All	0.419	0.704	.035	9	view →
DLBC	OS	Tertile	All	0.200	0.906	.012	6	view →
SARC	OS	Tertile	All	0.580	0.781	.033	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

UBTFL7–LIHC (DFS)

Open the LIHC breakdown →